SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017569
Filing Date
2023-05-15
Accepted
2023-05-15 17:28:45
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1342362
2 ex31-1.htm EX-31.1 12116
3 ex31-2.htm EX-31.2 12136
4 ex32-1.htm EX-32.1 7508
5 ex32-2.htm EX-32.2 7724
  Complete submission text file 0001493152-23-017569.txt   7126086

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sigy-20230331.xsd EX-101.SCH 36064
7 XBRL CALCULATION FILE sigy-20230331_cal.xml EX-101.CAL 47146
8 XBRL DEFINITION FILE sigy-20230331_def.xml EX-101.DEF 151108
9 XBRL LABEL FILE sigy-20230331_lab.xml EX-101.LAB 291249
10 XBRL PRESENTATION FILE sigy-20230331_pre.xml EX-101.PRE 258161
58 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1381441
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55575 | Film No.: 23924573
SIC: 3841 Surgical & Medical Instruments & Apparatus